These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The effect of doxorubicin on MEK-ERK signaling predicts its efficacy in HCC. Choi J; Yip-Schneider M; Albertin F; Wiesenauer C; Wang Y; Schmidt CM J Surg Res; 2008 Dec; 150(2):219-26. PubMed ID: 18468633 [TBL] [Abstract][Full Text] [Related]
24. Regulation of p38 phosphorylation and topoisomerase IIalpha expression in the B-cell lymphoma line Jiyoye by CD26/dipeptidyl peptidase IV is associated with enhanced in vitro and in vivo sensitivity to doxorubicin. Yamochi T; Yamochi T; Aytac U; Sato T; Sato K; Ohnuma K; McKee KS; Morimoto C; Dang NH Cancer Res; 2005 Mar; 65(5):1973-83. PubMed ID: 15753397 [TBL] [Abstract][Full Text] [Related]
25. 4-Amino-3-acetylquinoline-induced apoptosis of murine L1210 leukemia cells involves ROS-mitochondrial-mediated death signaling and activation of p38 MAPK. Jantová S; Repický A; Letasiová S; Cipák L Cell Biochem Funct; 2008; 26(5):609-19. PubMed ID: 18508389 [TBL] [Abstract][Full Text] [Related]
26. Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells. Kim CH; Han SI; Lee SY; Youk HS; Moon JY; Duong HQ; Park MJ; Joo YM; Park HG; Kim YJ; Yoo MA; Lim SC; Kang HS J Cell Physiol; 2007 May; 211(2):371-85. PubMed ID: 17309078 [TBL] [Abstract][Full Text] [Related]
27. 3,6-Dihydroxyflavone induces apoptosis in leukemia HL-60 cell via reactive oxygen species-mediated p38 MAPK/JNK pathway. Chang H; Lin H; Yi L; Zhu J; Zhou Y; Mi M; Zhang Q Eur J Pharmacol; 2010 Dec; 648(1-3):31-8. PubMed ID: 20840847 [TBL] [Abstract][Full Text] [Related]
28. Salvicine inactivates beta 1 integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling. Zhou J; Chen Y; Lang JY; Lu JJ; Ding J Mol Cancer Res; 2008 Feb; 6(2):194-204. PubMed ID: 18314480 [TBL] [Abstract][Full Text] [Related]
29. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214 [TBL] [Abstract][Full Text] [Related]
30. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels. Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917 [TBL] [Abstract][Full Text] [Related]
31. Antileukemic activity of lysophosphatidic acid acyltransferase-beta inhibitor CT32228 in chronic myelogenous leukemia sensitive and resistant to imatinib. La Rosée P; Jia T; Demehri S; Härtel N; de Vries P; Bonham L; Hollenback D; Singer JW; Melo JV; Druker BJ; Deininger MW Clin Cancer Res; 2006 Nov; 12(21):6540-6. PubMed ID: 17085669 [TBL] [Abstract][Full Text] [Related]
32. Spermidine/spermine N1-acetyltranferase modulation by novel folate cycle inhibitors in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Marverti G; Ligabue A; Guerrieri D; Paglietti G; Piras S; Costi MP; Farina D; Frassineti C; Monti MG; Moruzzi MS Gynecol Oncol; 2010 May; 117(2):202-10. PubMed ID: 20031193 [TBL] [Abstract][Full Text] [Related]
33. Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs. Tomek S; Horak P; Pribill I; Haller G; Rössler M; Zielinski CC; Pils D; Krainer M Gynecol Oncol; 2004 Jul; 94(1):107-14. PubMed ID: 15262127 [TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro. Khdair A; Handa H; Mao G; Panyam J Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331 [TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Paone A; Starace D; Galli R; Padula F; De Cesaris P; Filippini A; Ziparo E; Riccioli A Carcinogenesis; 2008 Jul; 29(7):1334-42. PubMed ID: 18566014 [TBL] [Abstract][Full Text] [Related]
36. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Effenberger-Neidnicht K; Schobert R Cancer Chemother Pharmacol; 2011 Apr; 67(4):867-74. PubMed ID: 20582416 [TBL] [Abstract][Full Text] [Related]
37. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate. Calderon-Aparicio A; Strasberg-Rieber M; Rieber M Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671 [TBL] [Abstract][Full Text] [Related]
38. In vitro effects of doxorubicin and tetrathiomolybdate on canine hemangiosarcoma cells. Sloan CQ; Rodriguez CO Am J Vet Res; 2018 Feb; 79(2):219-225. PubMed ID: 29359968 [TBL] [Abstract][Full Text] [Related]
39. Gambogic acid sensitizes ovarian cancer cells to doxorubicin through ROS-mediated apoptosis. Wang J; Yuan Z Cell Biochem Biophys; 2013 Sep; 67(1):199-206. PubMed ID: 23436279 [TBL] [Abstract][Full Text] [Related]
40. Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells. Kim SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ Tumour Biol; 2017 Feb; 39(2):1010428317692252. PubMed ID: 28218042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]